Published in Oral Oncol on July 20, 2006
Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer (2008) 1.15
Clinical features and differential diagnoses in laryngeal mucoepidermoid carcinoma. Clin Med Insights Pathol (2011) 0.98
P27/SKP-2 histochemical profile is relevant to malignant salivary gland tumors (MST) histogenesis and tumor grade. Head Neck Pathol (2011) 0.85
Clinicopathological analysis of salivary gland carcinomas and literature review. Mol Clin Oncol (2014) 0.84
Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy. Int J Exp Pathol (2010) 0.83
[Salivary gland mucoepidermoid carcinoma: unusual variants with detection of the t(11,19)(q21;p13) translocation]. Pathologe (2009) 0.82
Childhood bronchial mucoepidermoid tumors: A case report and literature review. Oncol Lett (2013) 0.80
Reconstruction of partial maxillectomy defect with a buccal fat pad flap and application of 4-hexylresorcinol: a case report. J Korean Assoc Oral Maxillofac Surg (2016) 0.77
An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma. Head Neck Pathol (2013) 0.77
Overexpression of the pituitary tumor transforming gene upregulates metastasis in malignant neoplasms of the human salivary glands. Exp Ther Med (2015) 0.76
Expression of parathyroid hormone-related protein confers malignant potential to mucoepidermoid carcinoma. Oncol Rep (2013) 0.75
Malignant salivary gland tumours of the head and neck region: a single institutions review. Pan Afr Med J (2015) 0.75
GSK3β and CREB3 gene expression profiling in benign and malignant salivary gland tumors. Iran Biomed J (2012) 0.75
Mucoepidermoid Carcinoma of Floor of the Mouth - A Rarity. J Clin Diagn Res (2015) 0.75
Mucoepidermoid carcinoma - unknown primary and late distant metastasis: an unusual course of the disease. Clin Pract (2011) 0.75
Mucoepidermoid Carcinoma of the Salivary Glands: Survival and Prognostic Factors. J Maxillofac Oral Surg (2016) 0.75
Prognostic value of proliferating cell nuclear antigen in parotid gland cancer. Eur Arch Otorhinolaryngol (2011) 0.75
Rosacea: a clinicopathological approach. Dermatology (2004) 2.20
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2006) 1.56
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
Hypoxemic reperfusion after 120 mins of intestinal ischemia attenuates the histopathologic and inflammatory response. Crit Care Med (2004) 1.50
Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol (2005) 1.43
Giant Basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res (2009) 1.43
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.17
Tumors of the submandibular gland: clinicopathologic analysis of 23 patients. J Oral Maxillofac Surg (2004) 1.15
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathol (2008) 1.13
The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int (2009) 1.13
Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Mod Pathol (2007) 1.09
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2008) 1.08
c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Urology (2004) 1.08
Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum Pathol (2007) 1.08
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits. Clin Ophthalmol (2011) 1.08
Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics (2005) 1.07
Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. Hum Pathol (2008) 1.06
Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol (2008) 1.06
Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients. Cytokine (2007) 1.05
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas. BMC Cancer (2006) 1.04
Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU Int (2005) 1.03
Analysis of PRNP gene codon 129 polymorphism in the Greek population. Eur J Epidemiol (2006) 1.01
Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology (2013) 1.01
Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. Eur Urol (2002) 1.01
Cranioectodermal dysplasia: a probable ciliopathy. Am J Med Genet A (2009) 1.01
Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis. Med Oncol (2010) 1.01
Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. Virchows Arch (2004) 1.00
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells. Mol Cancer (2010) 1.00
Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas. Histopathology (2012) 1.00
Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma. Clin Cancer Res (2008) 1.00
Transplacental infection of Coxsackievirus B3 pathological findings in the fetus. J Med Virol (2007) 0.99
Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry. Cytokine (2011) 0.99
Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas. Cancer J (2006) 0.98
Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol (2012) 0.97
Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berl) (2007) 0.96
Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res (2007) 0.96
Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors. Mol Cell Biochem (2007) 0.95
Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome. Hum Pathol (2010) 0.94
Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder. Virchows Arch (2008) 0.94
Pathologic, radiographic and molecular findings in three fetuses diagnosed with HEM/Greenberg skeletal dysplasia. Prenat Diagn (2008) 0.94
Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings. J Med Virol (2008) 0.93
Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece. Endocr Pathol (2010) 0.93
A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res (2007) 0.93
The combined evaluation of p27Kip1 and Ki-67 expression provides independent information on overall survival of ovarian carcinoma patients. Gynecol Oncol (2002) 0.93
Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep (2007) 0.93
Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int Orthop (2009) 0.93
Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93
Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer. Anticancer Res (2009) 0.92
Association of aberrant DNA methylation with clinicopathological features in breast cancer. Oncol Rep (2011) 0.92
The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma. Folia Histochem Cytobiol (2011) 0.92
Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol (2005) 0.92
A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features. Oncol Rep (2013) 0.92
ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World J Surg Oncol (2012) 0.91
Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. BMC Clin Pathol (2014) 0.91
High-level microsatellite instability is not involved in gallbladder carcinogenesis. Exp Mol Pathol (2005) 0.91
Malignant fibrous histiocytoma of the tongue: review of the literature and report of a case. J Oral Maxillofac Surg (2005) 0.91
Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report. Support Care Cancer (2008) 0.91
CD24 expression has a prognostic impact in breast carcinoma. Pathol Res Pract (2009) 0.91
Immunohistochemical evaluation of immune response in invasive ductal breast cancer of not-otherwise-specified type. Breast (2003) 0.91
EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays. Hepatogastroenterology (2006) 0.90
Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol (2007) 0.90
The prognostic significance of COX-2 and survivin expression in ovarian cancer. Pathol Res Pract (2008) 0.90
Calcifying epithelial odontogenic tumor (CEOT) of the mandible: clinical therapeutic conference. J Oral Maxillofac Surg (2005) 0.90
Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours. Histopathology (2010) 0.90
Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy. Cancer Chemother Pharmacol (2008) 0.90
NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links. Expert Opin Ther Targets (2014) 0.89
Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J Cancer Res Clin Oncol (2008) 0.89
Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis (2005) 0.89
Low-grade oligodendroglioma of the pineal gland: a case report and review of the literature. Diagn Pathol (2010) 0.88
Hypoxemic resuscitation prevents pulmonary capillary endothelial dysfunction induced by normoxemic resuscitation from hemorrhagic shock. Crit Care Med (2009) 0.88
Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: an experimental study. Atherosclerosis (2007) 0.87
Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development. Virchows Arch (2014) 0.87
Differential effect of Pistacia vera extracts on experimental atherosclerosis in the rabbit animal model: an experimental study. Lipids Health Dis (2010) 0.87
The role of endocannabinoids in pain modulation. Fundam Clin Pharmacol (2013) 0.86
Activation of mTOR signaling in medullary and aggressive papillary thyroid carcinomas. Surgery (2011) 0.86
Myocardial ischemia in intestinal postischemic shock: the effect of hypoxemic reperfusion. Crit Care Med (2003) 0.85
Insulinlike growth factor I receptor and estrogen receptor beta expressions are inversely correlated in colorectal neoplasms and affected by the insulin resistance syndrome. Hum Pathol (2007) 0.85
Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions. Tumour Biol (2013) 0.85
Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma. Pancreas (2007) 0.85
VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study. Oral Oncol (2008) 0.85
Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. Mol Cell Biochem (2006) 0.85
FGFR-2 and -3 play an important role in initial stages of oral oncogenesis. Anticancer Res (2007) 0.84
Synovial sarcoma of the tongue: report of a case and review of the literature. J Oral Maxillofac Surg (2008) 0.84
Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays. Pathol Oncol Res (2009) 0.84
The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Exp Gerontol (2012) 0.84